It can be inferred from this that NK4 antagonizes HGF/c-Met may inhibit the proliferation of laryngeal cancer cells and the formation of lymph vessels and microvessels in laryngeal cancer tissues, and block the occurrence, development and lymph node metastasis of laryngeal cancer. This evidence concerns the gene IL32 and laryngeal carcinoma.